Iovance Biotherapeutics Statistics
NASDAQ: IOVAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
13.18+0.265 (+2.05%)
Market open · Delayed 15 min · as of Oct 8, 1:29 PM ET
Iovance Biotherapeutics by the numbers
Iovance Biotherapeutics has a market capitalization of $5.97 billion based on 452.97M shares outstanding. With trailing EPS of $-0.69, Iovance Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 50.1% above its 50-day average and 169.2% above its 200-day average.
Average daily trading volume is 17.80M shares, or about $234.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IOVA valuation vs. peer median
| Metric | IOVA | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.97B | $5.10B | +17% |
| Avg. volume | 17.80M | 1.53M | +1066% |
Peer median across 8 companies: KOD, CGON, IMVT, SRRK, CRSP, ADPT, RLAY, TARS.
Valuation
- Market cap
- $5.97B
- Price / sales (latest FY)
- 22.66
- EPS (TTM)
- $-0.69
- Shares outstanding
- 452.97M
Price and trading
- Previous close
- 12.92
- Open
- 12.65
- Day range
- 12.62 – 13.23
- 52-week range
- 1.76 – 15.30
- 52-week change
- +492.43%
- Beta
- —
- Volume
- 6.93M
- Average volume
- 17.80M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 5.97B
- Forward Pe
- -55.61
- Eps
- -0.69
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.30
- Week52 Low
- 1.76
- Avg Volume
- 17.80M
- Shares Outstanding
- 452.97M
- Ma50
- 8.78
- Ma200
- 4.90
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -13.86%
- Pct From52w Low
- 648.86%